Vol. 6 No. 3 (2018): BUSINESS & MANAGEMENT STUDIES: AN INTERNATIONAL JOURNAL
Articles

EFFICIENCY OF PHARMACEUTICAL CONSUMPTION IN TURKEY: BENCHMARKING WITH OECD BY DEA

PDF
  • Çağla Pınar BOZOKLU,
  • Yasemin KESKİN BENLİ
Çağla Pınar BOZOKLU
Başkent Üniversitesi
Yasemin KESKİN BENLİ
Ankara Hacı Bayram Veli Üniversitesi
DOI: https://doi.org/10.15295/bmij.v6i3.351

Published 2018-11-29

How to Cite

BOZOKLU, Çağla P., & KESKİN BENLİ, Y. (2018). EFFICIENCY OF PHARMACEUTICAL CONSUMPTION IN TURKEY: BENCHMARKING WITH OECD BY DEA. Business & Management Studies: An International Journal, 6(3), 253–262. https://doi.org/10.15295/bmij.v6i3.351

Abstract

After 1980s, consumers begin to focus more health-conscious behaviours and attitudes including the concept of consuming pharmaceutical products. Pharmaceutical consumption attitude is a natural outcome of this trend. In this research, it is aimed to analyze Turkey’s benchmarking position among OECD countries in terms of pharmaceutical consumption efficiency. 15 OECD countries’ 5 years (2008-2012) analyzed by DEA-Malmquist TFP with the output-oriented and variable returns to scale methods. TC index shows that Turkey had created more pharmaceutical consumption and longer life expectancy by using same amount of number of physicians, number of pharmacists, total public and private health insurance expenditures and number of doctor consultations. By the way, Turkey had embraced efficiency growth with the rate of 0.4 percent. However, total efficiency level of Turkey got damaged by reason of its administrative limitations.

PDF

Downloads

Download data is not yet available.

References

  1. Angelidis, D., and Lyroudi. K. (2005), “The magnitude of off balance sheet activities for the evaluation of banking productivity. In International Conference on Finance, Copenhagen, September.
  2. Boussofiane, A., R. G., Dyson, and Thanassoulis.E. (1991), “Applied data envelopment analysis.” European Journal of Operational Research, Vol. 52, No. 1, pp. 1-15.doi: 0377-2217(91)90331-O
  3. Benli, Y. K. and Bozoklu. Ç. P. (2016), “Complexity of Measuring Advertising Efficiency: An Application of DEA Method in Turkey.” In Şule Erçetin (Ed.), Chaos, Complexity and Leadership 2014 Springer: Cham., pp. 193-207.
  4. Charnes, A., Cooper, W. W., and Rhodes E. (1978), “Measuring the efficiency of decision making units.” European Journal of Operational Research Vol. 2, pp. 429–444.doi: 0377-2217(78)90138-8
  5. Crémieux, P. Y., Meilleur, M. C., Ouellette, P., Petit, P., Zelder, M., and Potvin K. (2005), “Public and private pharmaceutical spending as determinants of health outcomes in Canada.” Health economics Vol. 14, No. 2, pp. 107-116.doi: 10.1002/hec.922
  6. Coelli, T.J. (1996), A Guide to DEAP Version 2.1: A Data Envelopment Analysis (Computer)Program. CEPA Working Paper 96/8, Department of Econometrics, University of New England.
  7. Cooper, W. W., Seiford, L. M., and Tone, K. (2007), “The CCR Model and production correspondence. Data envelopment analysis: A comprehensive text with models, applications, references and DEA-Solver Software, pp. 41-85.
  8. Deliktaş, E. (2002), “Türkiye özel sektör imalât sanayiinde etkinlik ve toplam faktör verimliliği analizi.” ODTÜ Gelişme Dergisi Vol. 29, No. 3–4, pp. 247–284.
  9. Dormont, B., Grignon, M., and Huber. H. (2006), “Health expenditure growth: reassessing the threat of ageing.” Health economics Vol. 15, No. 9, pp. 947-963.doi: 10.1002/hec.1165
  10. El-Shinnawy, A. (2010), “Trends of Total Factor Productivity in Egypt's Pharmaceutical Industry: Evidence from The Nonparametric Malmquist Index Approach. In ERF 16th Annual Conference, Economic Research Forum, Cairo, May.
  11. Ersoy, K., Kavuncubasi, S., Ozcan, Y. A., and Harris J. M. (1997), “Technical efficiencies of Turkish hospitals: DEA approach.” Journal of Medical Systems Vol. 21, No. 2, pp. 67–74.doi: A:1022801222540
  12. Frech, H. E., and Miller, R. D. (2004) “The effects of pharmaceutical consumption and obesity on the quality of life in the Organization of Economic Cooperation and Development (OECD) countries.” Pharmacoeconomics Vol. 22, No. 2, pp. 25-36.doi: 00019053-200422002-00004
  13. Hollingsworth, B., and Parkin, D. (1997), “The efficiency of Scottish acute hospitals—An application of data envelopment analysis.” Mathematical Medicine and Biology: A Journal of IMA Vol. 12 pp. 161–173.doi: 10.1093/imammb/12.3-4.161
  14. Huang, Y.G.L. (1986), “An evaluation of the efficiency of rural primary care programs: An application of data envelopment analysis in Chapel Hill, North Carolina.” PhD Diss., School of Public Health, University of North Carolina.
  15. Huang, Y.G.L. (1990), “An application of data envelopment analysis: Measuring the relative performance of Florida general hospitals.” Journal of Medical Systems Vol. 14, pp. 191, 1990.doi: 10.1007/BF00999268
  16. Ji, Y. B., and Lee, C. (2010), “Data envelopment analysis.” The Stata Journal Vol. 10, No. 2, pp. 267-280.
  17. Karacabey, A.A. (2002), “Türk bankalarındaki üretim değişiklikleri ve nedenleri.” Iktisat Isletme Finans Vol. 17, No. 191, pp. 68–78.
  18. Kesbiç CY, Tokatlıoğlu, İ, Ürüt, S. (2004), “Rekabet gücü göstergeleri: Türk imalat sanayi için Veri Zarflama Analizi-Malmquist toplam faktör verimliliği endeksi uygulaması.” Iktisat Isletme Finans Vol. 19, No. 220, pp. 63–75.
  19. Keskin Benli, Y. (2006), İstanbul Menkul Kıymetler Borsası imalat sanayi için etkinlik ve toplam faktör verimliliği analizi. Seçkin Yayıncılık: Ankara.
  20. Keskin Benli, Y. (2012) “Data Envelopment Analysis (DEA) and Malmquist Total Factor Productivity (TFP): An Empirical Evidence in Accommodation Businesses.” Ege Akademik Bakis Vol. 12, No. 3, pp. 369.
  21. Keskin, B. Y., and Degirmen, S. (2013), “The application of data envelopment analysis based Malmquist total factor productivity index: Empirical evidence in Turkish banking sector.” Panoeconomicus Vol. 60, No. 2, pp. 139-159.doi: 10.2298/PAN1302139K
  22. Kirigia, J. M., Emrouznejad, A., Sambo, L. G., Munguti, N., and Liambila W. (2004), “Using data envelopment analysis to measure the technical efficiency of public health centers in Kenya.” Journal of Medical Systems Vol. 28, No. 2, pp. 155-166.doi: 10.1023/B:JOMS.0000023298.31972.c9
  23. Kooreman, P. (1994), “Nursing-home care in the Netherlands—A nonparametric efficiency analysis.” Journal of Health Economics Vol. 13, pp. 345–346.doi: 10.1016/0167-6296(94)90029-9
  24. Lexchin, J. (2001), “Lifestyle drugs: issues for debate.” Canadian Medical Association Journal Vol. 164, No. 10, pp. 1449-1451.
  25. Lin, Y. H., and Hong, C. F. (2015), “Efficiency and productivity of publicly-traded bio-pharmaceutical companies in Taiwan.” In Industrial Engineering and Engineering Management (IEEM), 2015 IEEE International Conference, December, pp. 1328-1331.
  26. Liu, J., Ding, F. Y., and Lall, V. (2000), “Using data envelopment analysis to compare suppliers for supplier selection and performance improvement.” Supply Chain Management: An International Journal Vol. 5, No. 3, pp. 143-150.doi: 10.1108/13598540010338893
  27. Majumdar, S. K. (1994), “Assessing firms capabilities—theory and measurement—as study of Indian pharmaceutical industry.” Economic Policy Weekly Vol. 29, pp. M83–M89.
  28. Ozcan, Y. A., and Bannick, R. R. (1994), “Trends in department-of-defense hospital efficiency.” Journal of Medical Systems Vol. 18, pp. 69–83.doi: 10.1007/BF00999453
  29. Ozcan, Y. A., Mccue, M. J., and Okasha, A. A. (1996), “Measuring the technical efficiency of psychiatric hospitals.” Journal of Medical Systems Vol. 20, pp. 141–150.doi: 10.1007/BF02281992
  30. Özdemir, E., Kılıç, S., and Aydın, Z. B. (2010), “Sosyal güvenlik reformu sonrası tüketici olarak hastaların hastane seçimi: Pazarlama açısından bir alan araştırması.” Uludağ Üniversitesi İktisadi ve İdari Bilimler Fakültesi Dergisi Sayı 29, Cilt 1, pp. 1-27.
  31. Parkin, D., and Hollingsworth, B. (1997), “Measuring production efficiency of acute hospitals in Scotland 1991–94: Validity issues in data envelopment analysis.” Applied Economics Vol. 29, No. 11, pp. 1425–1433.doi: 10.1080/000368497326255
  32. Reich, M. R. (1994), “Bangladesh pharmaceutical policy and politics.” Health Policy and Planning Vol. 9, No. 2, pp. 130-143.doi: 10.1093/heapol/9.2.130
  33. Retzlaff-Roberts, D., Chang, C. F., and Rubin, R. M. (2004), “Technical efficiency in the use of health care resources: A comparison of OECD countries.” Health Policy Vol. 69, No. 1, pp. 55-72.doi: 10.1016/j.healthpol.2003.12.002
  34. Rüütel, D., and Pudersell, K. (2011), “Pharmaceutical policy and the effects of the economic crisis: Estonia.” Eurohealth Vol. 17, No. 1, pp. 5.
  35. Shaw, J., and Baker M. (2004), “‘Expert patient’—dream or nightmare?: The concept of a well-informed patient is welcome, but a new name is needed.” BMJ: British Medical Journal Vol. 328, No. 7442, pp. 723.doi: 10.1136/bmj.328.7442.723
  36. Song, H., and Zhang, R. (2013), “R&D efficiency appraisal of pharmaceutical industry based on DEA-Malmquist.” Journal of Chemical and Pharmaceutical Research Vol. 5, No. 11, pp. 195-199.
  37. Thanassoulis, E., Boussfofiane, A., and Dyson, R. G. (1995), “Exploring output quality targets in the provision of perinatal-care in England using data envelopment analysis.” European Journal of Operational Research Vol. 80, pp. 588–607.doi: 10.1016/0377-2217(94)00139-4
  38. TSI (Turkish Statistical Institute) (2017), Statistics of Health Expenditure, http://www.tuik.gov.tr/PreTablo.do?alt_id=1084 accessed at 17.09.2017
  39. Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., and Laxminarayan, R. (2014), “Global antibiotic consumption 2000 to 2010: An analysis of national pharmaceutical sales data.” The Lancet Infectious Diseases Vol. 14, No. 8, pp. 742-750.doi. 10.1016/S1473-3099(14)70780-7